证券记录 · 已归档季度
TEVA
Teva Pharmaceutical Industries Limited · Healthcare · Drug Manufacturers - Specialty & Generic
18被追踪持有人
-3Δ持有人
84.56M持有股份
$1.30B报告持仓市值
+0新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -14.3% ·
股份流向 -5.8% ·
净新建仓位 -16.7%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 151 | +7 | 369.28M | $12.48B | +9 | −1 |
| Q1 2026 | 146 | +3 | 327.68M | $9.78B | +10 | −8 |
| Q4 2025 | 144 | -1 | 326.44M | $10.18B | +3 | −3 |
| Q3 2025 | 23 | 0 | 176.53M | $3.56B | +1 | −2 |
| Q2 2025 | 21 | 0 | 197.53M | $3.31B | — | — |
| Q1 2025 | 18 | -3 | 84.56M | $1.30B | — | −3 |
| Q4 2024 | 21 | -1 | 89.79M | $1.98B | — | −1 |
| Q3 2024 | 21 | +2 | 78.93M | $1.23B | +2 | — |
| Q2 2024 | 19 | — | 61.88M | $1.01B | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 17.32M | -10.8% | $266.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Duquesne Family Office ✦ | 14.88M | +65.4% | $228.70M | 7.7% | ▲ Add | 3 | SEC ↗ |
| 3 | Glenview Capital ✦ | 14.78M | +74.8% | $227.15M | 5.6% | ▲ Add | 4 | SEC ↗ |
| 4 | Viking Global Investors ✦ | 10.13M | +55.7% | $155.63M | 0.5% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 9.19M | -0.9% | $140.57M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 9.19M | -0.9% | $140.57M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Millennium Management ✦ | 5.50M | -16.0% | $84.47M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 5.30M | -24.0% | $81.48M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 2.85M | +19.6% | $43.85M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 2.85M | +19.6% | $43.85M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Norges Bank ✦ (被动) | 2.59M | +47.8% | $39.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Greenlight Capital (DME Capital) ✦ | 568.20K | +21.3% | $8.73M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 13 | Greenlight Capital (DME Capital) ✦ | 568.20K | +21.3% | $8.73M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 484.00K | -59.7% | $7.44M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 405.69K | -80.2% | $6.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 405.69K | -80.2% | $6.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 138.14K | -25.7% | $2.12M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 136.80K | -80.1% | $2.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 93.20K | -11.7% | $1.43M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | ARK Investment Management ✦ | 90.25K | -10.2% | $1.39M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 81.18K | -96.8% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 23.95K | +24.6% | $368,195 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 23.95K | +24.6% | $368,195 | 0.0% | ▲ Add | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Arrowstreet Capital | $154.07M | 曾为 0.1% |
| Marshall Wace | $113.63M | 曾为 0.1% |
| Bridgewater Associates | $207,022 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 646 持有人, 666.61M 股份, $16.70B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Lippman Evan
Officer · 18.60K 股 · $680,291
Aug 05
Zaks Tal Zvi
Director · 17 股 · $593
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据